Fed Sparks Profit T...
Health Care: Drugs
Titan Pharmaceuticals Incorporated (TTNP: OTC)
$0.52 -0.02 | -3.15%
05/24/13 - 03:58 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2007 | |
| Sales | 7.12M | 4.07M | 10.09M | 24.00K |
| Cost of Sales | 0.00 | 0.00 | 0.00 | -288.00K |
| Gross Operating Profit | 7.12M | 4.07M | 10.09M | 312.00K |
| Selling, General, and Administrative Expenses | 4.88M | 3.37M | 3.26M | 6.21M |
| Research & Development | 10.61M | 11.21M | 12.86M | 12.24M |
| Operating Income before D & A (EBITDA) | -8.37M | -10.51M | -6.02M | -18.14M |
| Depreciation & Amortization | 17.00K | 1.55M | 85.00K | 288.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 646.00K |
| Other Income - Net | -1.95M | 1.73M | -131.00K | 140.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -10.34M | -10.32M | -6.24M | -17.65M |
| Interest Expense | 4.86M | 6.43M | 678.00K | 0.00 |
| Pre-Tax Income | -15.20M | -16.76M | -6.92M | -17.65M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -15.18M | 0.00 | 0.00 | -17.65M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -15.18M | 0.00 | 0.00 | -17.65M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -15.18M | -15.20M | -6.83M | -17.65M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-15.18M | 0.00 | 0.00 | -17.65M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -15.18M | 0.00 | 0.00 | -17.65M |
| Basic EPS from Continuing Ops. | -0.23 | -0.26 | -0.09 | -0.41 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.23 | -0.26 | -0.09 | -0.41 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.23 | -0.26 | -0.09 | -0.41 |
| Basic Normalized Net Income/Share | -0.23 | n.a. | n.a. | -0.41 |
| EPS fr Continuing Ops. | -0.23 | -0.26 | -0.09 | -0.41 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.23 | -0.26 | -0.09 | -0.41 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.23 | -0.26 | -0.09 | -0.41 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.23 | n.a. | n.a. | -0.41 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with TTNP
- Portfolio NameUser Type
- UserJKE 1
Latest TTNP Headlines from TheStreet
- FDA Rejection of Titan's Probuphine Looks Like a Mugging 05.01.13 | 05:05 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Titan Pharma: FDA Panel Live Blog 03.21.13 | 07:03 am
- The Next Big Thing In Biotech: Titan
03.14.13 | 12:03 pm - Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Titan Pharma: Run-Up Trade Into March FDA Panel 01.31.13 | 06:01 am
Press Releases for TTNP
- Top Stocks On The Move: Medi Swipe Inc., New Western Energy Corp., Titan Pharmaceuticals Inc., And Advanced Cell Technology Inc. - PR Newswire 01.07.13 | 09:01 am
- Titan Reports Fourth Quarter 2010 Fanapt® Royalty - PR Newswire 02.03.11 | 09:02 pm
Partner Headlines for TTNP
